Annual Biotech Closures Overview

The episode examines the annual tracking of biotech closures, highlighting 22 companies identified as having shut down or in the process of winding down in 2024. This represents a decrease from the previous year, which reported 27 closures, but a significant increase compared to only seven closures in 2022. The hosts emphasize the methodology used to identify these closures, which includes monitoring public companies through legal filings and SEC documents while relying on investigative efforts and tips for private companies. They stress the importance of community engagement, urging listeners to provide information about lesser-known biotech closures to enhance the tracking process.